chr3-64522237-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_182920.2(ADAMTS9):āc.5742A>Gā(p.Lys1914=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00898 in 1,613,998 control chromosomes in the GnomAD database, including 75 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0054 ( 3 hom., cov: 33)
Exomes š: 0.0093 ( 72 hom. )
Consequence
ADAMTS9
NM_182920.2 synonymous
NM_182920.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0700
Genes affected
ADAMTS9 (HGNC:13202): (ADAM metallopeptidase with thrombospondin type 1 motif 9) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. Members of the ADAMTS family have been implicated in the cleavage of proteoglycans, the control of organ shape during development, and the inhibition of angiogenesis. This gene is localized to chromosome 3p14.3-p14.2, an area known to be lost in hereditary renal tumors. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 3-64522237-T-C is Benign according to our data. Variant chr3-64522237-T-C is described in ClinVar as [Benign]. Clinvar id is 789164.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.07 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS9 | NM_182920.2 | c.5742A>G | p.Lys1914= | synonymous_variant | 39/40 | ENST00000498707.5 | NP_891550.1 | |
ADAMTS9 | NM_001318781.2 | c.5658A>G | p.Lys1886= | synonymous_variant | 38/39 | NP_001305710.1 | ||
ADAMTS9 | XR_007095711.1 | n.6001A>G | non_coding_transcript_exon_variant | 38/40 | ||||
ADAMTS9 | XR_245151.1 | n.6085A>G | non_coding_transcript_exon_variant | 39/41 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS9 | ENST00000498707.5 | c.5742A>G | p.Lys1914= | synonymous_variant | 39/40 | 1 | NM_182920.2 | ENSP00000418735 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00544 AC: 829AN: 152250Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
829
AN:
152250
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00596 AC: 1498AN: 251372Hom.: 14 AF XY: 0.00580 AC XY: 788AN XY: 135844
GnomAD3 exomes
AF:
AC:
1498
AN:
251372
Hom.:
AF XY:
AC XY:
788
AN XY:
135844
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00935 AC: 13664AN: 1461630Hom.: 72 Cov.: 30 AF XY: 0.00908 AC XY: 6601AN XY: 727128
GnomAD4 exome
AF:
AC:
13664
AN:
1461630
Hom.:
Cov.:
30
AF XY:
AC XY:
6601
AN XY:
727128
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00544 AC: 829AN: 152368Hom.: 3 Cov.: 33 AF XY: 0.00486 AC XY: 362AN XY: 74528
GnomAD4 genome
AF:
AC:
829
AN:
152368
Hom.:
Cov.:
33
AF XY:
AC XY:
362
AN XY:
74528
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
ADAMTS9-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at